Page last updated: 2024-11-11

bakuchiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bakuchiol: chief component of Psoralea corylifolia Linn; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
PsoraleagenusA plant genus of the family FABACEAE that is a source of psoralen (FICUSIN).[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]
Psoralea corylifoliaspecies[no description available]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID5468522
CHEMBL ID262344
SCHEMBL ID9921172
SCHEMBL ID9928857
MeSH IDM0060030

Synonyms (47)

Synonym
AC-13779
up-256
nsc-671195
(+)-bakuchiol
phenol, 4-(3-ethenyl-3,7-dimethyl-1,6-octadienyl)-, (s-(e))-
c18h24o
4-(3-ethenyl-3,7-dimethyl-1,6-octadienyl)phenol
bakuchiol
phenol, 4-[(1e,3s)-3-ethenyl-3,7-dimethyl-1,6-octadienyl]-
10309-37-2
4-[(1e,3s)-3,7-dimethyl-3-vinyl-octa-1,6-dienyl]phenol
CHEMBL262344
up 256
sytenol a
(s)-bakuchiol
4-[(1e,3s)-3-ethenyl-3,7-dimethylocta-1,6-dienyl]phenol
p-(3,7-dimethyl-3-vinylocta-trans-1,6-dimethyl) phenol
AKOS015961387
unii-ot12hju3ar
ot12hju3ar ,
(s)-(+)-bakuchiol
phenol, 4-((1e,3s)-3-ethenyl-3,7-dimethyl-1,6-octadienyl)-
bakuchiol [inci]
phenol, 4-((1e,3s)-3-ethenyl-3,7-dimethyl-1,6-octadien-1-yl)-
(s,e)-4-(3,7-dimethyl-3-vinylocta-1,6-dien-1-yl)phenol
CCG-208650
CCG-207939
CS-3749
SCHEMBL9921172
SCHEMBL9928857
AC-33943
HB0129
HY-N0235
J-000870
bakuchiol, analytical standard
AS-67675
4-[(1e,3s)-3-ethenyl-3,7-dimethylocta-1,6-dien-1-yl]phenol
bdbm50478311
bakuchiol, >=95%
Q4849590
3,5-dihydroxytoluene (orcinol monohydrate / anhydride? )
(s)-4-(3,7-dimethyl-3-vinylocta-1,6-dien-1-yl)phenol
2197131-28-3
A14770
4-[(1e,3s)-3-ethenyl-3,7-dimethyl-1,6-octadien-1-yl]phenol
A896623
DTXSID401035664

Research Excerpts

Overview

Bakuchiol (BAK) is a prenylated phenolic mono-terpene extracted from the fruit of Psoralea corylifolia L. It exerts a protective effect on organs. Bakuchiol is a promising anti-tumor candidate with resveratrol-like structure.

ExcerptReferenceRelevance
"Bakuchiol is a meroterpene natural product distributed in various plants. "( Recent Advances in the Chemistry and Biology of Bakuchiol and its Derivatives: An Updated Review.
Gupta, N; Gupta, S; Sangwan, PL; Shankar, R, 2023
)
2.61
"Bakuchiol is a retinol alternative with anti-aging, antibacterial, and anti-inflammatory properties. "( Applications of bakuchiol in dermatology: Systematic review of the literature.
Chandan, N; Puyana, C; Tsoukas, M, 2022
)
2.51
"Bakuchiol is a monoterpene phenol isolated from the seeds of Psoralea corylifolia Linn. "( Bakuchiol: A Potential Anticancer Compound from
Chaudhary, J; Chopra, B; Dhingra, AK; Grewal, AS; Grover, P; Jain, A, 2023
)
3.8
"Bakuchiol, is a principal bioactive component present in seeds of Psoralea corylifolia. "( Therapeutic and Health Promoting Potential of Bakuchiol from
Chopra, B; Dhingra, AK, 2023
)
2.61
"Bakuchiol is a new trendy ingredient in cosmetic skincare products, claiming to have similar efficacy to over-the-counter vitamin A derivative products. "( Cosmetic commentary: Is bakuchiol the new "skincare hero"?
Spierings, NMK, 2020
)
2.31
"Bakuchiol (BAK) is a prenylated phenolic mono-terpene extracted from the fruit of Psoralea corylifolia L., which exerts a protective effect on organs. "( Bakuchiol from Psoralea corylifolia L. Ameliorates acute kidney injury and improves survival in experimental polymicrobial sepsis.
Chen, Y; Deng, D; Liu, Z; Luo, J; Luo, M; Shen, J; Wang, J; Xiao, J; Zeng, Z, 2020
)
3.44
"Bakuchiol is a phytochemical that has demonstrated cutaneous antiageing effects when applied topically. "( Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing.
Bosanac, S; Burney, W; Dhaliwal, S; Ellis, SR; Foolad, N; Nguyen, M; Notay, M; Reiter, P; Rybak, I; Sivamani, RK; Trivedi, M; Vaughn, AR; Yan, H, 2019
)
2.2
"Bakuchiol is a phytoestrogen isolated from the seeds of Psoralea corylifolia L."( Bidirectional regulation of bakuchiol, an estrogenic-like compound, on catecholamine secretion.
Fan, G; Gao, XM; Ma, S; Mao, H; Niu, Z; Wang, H; Wang, Y; Xu, Y; Zhang, H; Zhu, Y, 2014
)
1.42
"Bakuchiol is a meroterpene phenol abundant in seeds and leaves of the plant Psoralea corylifolia. "( Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects.
Bojanowski, K; Chaudhuri, RK, 2014
)
3.29
"Bakuchiol is a promising anti-tumor candidate with resveratrol-like structure. "( Inhibition potential of UDP-glucuronosyltransferases (Ugts) 1A isoforms by the analogue of resveratrol, bakuchiol.
Cao, YF; Dong, DG; Fang, ZZ; Guo, EM; Lv, J; Zhang, SL; Zhang, Y, 2014
)
2.06
"Bakuchiol is a phenolic isoprenoid compound present in Babchi (Psoralea corylifolia L.) seeds."( Bakuchiol Is a Phenolic Isoprenoid with Novel Enantiomer-selective Anti-influenza A Virus Activity Involving Nrf2 Activation.
Arakaki, Y; Esumi, T; Kido, H; Kohnomi, S; Konishi, S; Kuzuhara, T; Shoji, M; Suzuki, Y; Takahashi, E; Yamamoto, C, 2015
)
2.58
"Bakuchiol is a meroterpene present in the medicinal plant Psoralea corylifolia, which has been traditionally used in China, India, Japan and Korea for the treatment of premature ejaculation, knee pain, alopecia spermatorrhea, enuresis, backache, pollakiuria, vitiligo, callus, and psoriasis. "( Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase.
Bode, AM; Dong, Z; Heo, YS; Kim, JE; Kim, JH; Lee, KW; Lee, Y; Yang, H, 2016
)
3.32
"Bakuchiol is a natural anti-inflammatory agent able to control leukocytic functions such as eicosanoid production, migration and degranulation in the inflammatory site."( Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice.
Alcaraz, MJ; Erazo, S; Ferrándiz, ML; Gil, B; González, E; Negrete, R; Pacheco, S; Payá, M; Sanz, MJ; Ubeda, A, 1996
)
1.42
"Bakuchiol is a major component of Corylifoliae Fructus (Psoralea corylifolia L.) and has been clarified to have cytotoxic activity. "( [Cytotoxicity of corylifoliae fructus. II. Cytotoxicity of bakuchiol and the analogues].
Dohi, T; Iwamura, J; Kubo, M; Odani, T; Tanaka, H, 1989
)
1.96

Effects

Bakuchiol (BAK) has been reported to have a diverse pharmacological property. Bakuchiol has antiinflammatory, antipyretic, antibacterial antiviral, anticancer, and estrogenic activity but appears to be hepatotoxic in in vitro tests.

ExcerptReferenceRelevance
"Bakuchiol has a three-fold higher binding affinity for ERalpha than for ERbeta."( Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats.
Ahn, J; Ha, TY; Kim, S; Kim, SR; Lim, SH; Park, HJ, 2009
)
1.31
"Bakuchiol (BAK) has been reported to have a diverse pharmacological property as an antibiotic, anti-cancer, anti-hypolipidemic, anti-inflammatory and anti-convulsant agent. "( Evaluation of the immunomodulatory and anti-inflammatory activity of Bakuchiol using RAW 264.7 macrophage cell lines and in animal models stimulated by lipopolysaccharide (LPS).
Ahmed, Z; Chauhan, N; Gupta, N; Kaul, A; Kumar Nagar, R; Kumar, A; Sangwan, PL; Satheesh Kumar, P; Sawhney, G; Yadav, G, 2021
)
2.3
"Bakuchiol (BAK) has antiinflammatory, antipyretic, antibacterial antiviral, anticancer, and estrogenic activity but appears to be hepatotoxic in in vitro tests."( Bakuchiol Contributes to the Hepatotoxicity of Psoralea corylifolia in Rats.
Abulizi, A; Aibai, S; Jiang, ZZ; Li, ZJ; Wang, T; Zhang, LY; Zhao, GL; Zhou, F, 2017
)
2.62
"Bakuchiol has also demonstrated multiple pharmacologic activities."( Characterization of glutathione conjugates derived from reactive metabolites of bakuchiol.
Chi, M; Peng, Y; Zheng, J, 2016
)
1.38
"Bakuchiol (Bak) has been reported to confer protection against inflammation and oxidative stress."( Bakuchiol Protects Against Acute Lung Injury in Septic Mice.
Chang, N; Han, Z; Li, J; Ye, M; Zhang, J; Zhang, X; Zhang, Y, 2017
)
2.62
"Bakuchiol has a three-fold higher binding affinity for ERalpha than for ERbeta."( Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats.
Ahn, J; Ha, TY; Kim, S; Kim, SR; Lim, SH; Park, HJ, 2009
)
1.31

Actions

The bakuchiol can enhance ESF-1 cell activity, promote collagen and matrix metalloproteinase inhibitors mRNA expression level. Bakuchiol also plays a significant role in mental disorders.

ExcerptReferenceRelevance
"Bakuchiol also plays a significant role in mental disorders."( Therapeutic and Health Promoting Potential of Bakuchiol from
Chopra, B; Dhingra, AK, 2023
)
1.89
"The bakuchiol can enhance ESF-1 cell activity, promote collagen and matrix metalloproteinase inhibitors mRNA expression level and inhibit mRNA expression of matrix metalloproteinases in order to postpone skin aging."( [Regulative effect of bakuchiol on ESF-1 cells anti-aging gene].
Li, JM; Wang, S; Xu, YM; Yu, Q; Zhang, N; Zou, HM, 2014
)
1.28

Treatment

Bakuchiol and PCE treatments had no uterotrophic activity even though they demonstrated oestrogenic activity in the in vitro assays. Bakuchiol significantly inhibited lipid peroxidation and intracellular glutathione depletion in hepatocytes induced by tBH, CCl4 or D-GalN.

ExcerptReferenceRelevance
"Bakuchiol treatment significantly inhibited NUGC3 human gastric cancer cell viability in a concentration dependent manner."( Anti‑tumor effects of bakuchiol on human gastric carcinoma cell lines are mediated through PI3K/AKT and MAPK signaling pathways.
Liu, B; Lv, L, 2017
)
1.49
"Bakuchiol and PCE treatments had no uterotrophic activity even though they demonstrated oestrogenic activity in the in vitro assays."( Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats.
Ahn, J; Ha, TY; Kim, S; Kim, SR; Lim, SH; Park, HJ, 2009
)
1.31
"Bakuchiol treatment (25 and 50 mg/kg, p.o.) also significantly reduced the levels of aspartate transaminase and alanine transaminase in an acute liver injury model induced by D-GalN."( Protective effect of (S)-bakuchiol from Psoralea corylifolia on rat liver injury in vitro and in vivo.
Kim, YC; Park, EJ; Sohn, DH; Zhao, YZ, 2005
)
1.35
"Bakuchiol treatment stimulated the activation of extracellular signal-regulated kinase 1/2 (ERK), c-Jun NH2-terminal protein kinase (JNK), and p38 mitogen-activated protein kinases (MAPK) in vitro."( Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts.
Kim, YC; Park, EJ; Sohn, DH; Zhao, YZ, 2007
)
2.5
"Treatment with bakuchiol significantly inhibited lipid peroxidation and intracellular glutathione depletion in hepatocytes induced by tBH, CCl4 or D-GalN."( Protective effect of (S)-bakuchiol from Psoralea corylifolia on rat liver injury in vitro and in vivo.
Kim, YC; Park, EJ; Sohn, DH; Zhao, YZ, 2005
)
0.97

Toxicity

ExcerptReferenceRelevance
"To study the toxicokinetics of bakuchiol, hepatic and renal toxicity in rats after single oral administration of Psoraleae Fructus and combined with Glycyrrhizae Radix et Rhizoma, in order to provide scientific evidences for clinical safe medication use."( [Toxicokinetics of bakuchiol, hepatic and renal toxicity in rats after single oral administration of Psoraleae Fructus and combination with Glycyrrhizae Radix et Rhizoma].
Gong, Z; Ma, NN; Shi, SZ; Wang, Q; Yang, JL; Zhao, ZJ, 2015
)
1.03

Pharmacokinetics

In this paper, pharmacokinetic study was conducted to obtain pharmacokinetics parameters of bakuchiol. The method was applied to a pharmacokinetically study of bAKuchiol intravenously administered to rats at a dose of 5 mg/kg.

ExcerptReferenceRelevance
"In this paper, pharmacokinetic study was conducted to obtain pharmacokinetic parameters of bakuchiol."( In vivo pharmacokinetics of bakuchiol after oral administration of bakuchiol extraction in rat plasma.
Chang, YX; Gao, XM; Kang, LY; Li, J; Liu, EW; Wang, YF; Yan, DM, 2010
)
0.88
" The main pharmacokinetic parameters of bakuchiol in rat were obtained based on the analysis of the plasma sample."( In vivo pharmacokinetics of bakuchiol after oral administration of bakuchiol extraction in rat plasma.
Chang, YX; Gao, XM; Kang, LY; Li, J; Liu, EW; Wang, YF; Yan, DM, 2010
)
0.92
" The method was applied to a pharmacokinetic study of bakuchiol intravenously administered to rats at a dose of 5 mg/kg."( Ultra-high-performance liquid chromatography-tandem mass spectrometry for pharmacokinetics of bakuchiol in rats.
Fan, YM; Zhang, SQ, 2014
)
0.87
" The developed method was applied to evaluating the pharmacokinetic study of 13 bioactive compounds after oral administration of Psoraleae Fructus in rat of different genders."( Simultaneous characterization of multiple Psoraleae Fructus bioactive compounds in rat plasma by ultra-high-performance liquid chromatography coupled with triple quadrupole mass spectrometry for application in sex-related differences in pharmacokinetics.
Cheng, LY; Song, L; Wu, YL; Yang, L; Yu, YL; Zhang, Y; Zhou, K; Zhou, ZX, 2020
)
0.56

Compound-Compound Interactions

ExcerptReferenceRelevance
"To study the toxicokinetics of bakuchiol, hepatic and renal toxicity in rats after single oral administration of Psoraleae Fructus and combined with Glycyrrhizae Radix et Rhizoma, in order to provide scientific evidences for clinical safe medication use."( [Toxicokinetics of bakuchiol, hepatic and renal toxicity in rats after single oral administration of Psoraleae Fructus and combination with Glycyrrhizae Radix et Rhizoma].
Gong, Z; Ma, NN; Shi, SZ; Wang, Q; Yang, JL; Zhao, ZJ, 2015
)
1.03

Bioavailability

ExcerptReferenceRelevance
" The oral bioavailability of bakuchiol in rats (3."( Pre-column derivatization combined with UHPLC-MS/MS for rapid and sensitive quantification of bakuchiol in rat plasma.
Li, H; Yuan, M; Zhong, Y; Zhuang, X, 2013
)
0.9
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)IC50 (µMol)6.10000.00031.38338.4000AID327961
Hypoxia-inducible factor 1-alphaHomo sapiens (human)IC50 (µMol)6.10000.00072.46529.2100AID327961
Endothelial PAS domain-containing protein 1Homo sapiens (human)IC50 (µMol)6.10000.00302.60028.5100AID327961
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (98)

Processvia Protein(s)Taxonomy
positive regulation of chemokine-mediated signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of signaling receptor activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to hypoxiaHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to reactive oxygen speciesHypoxia-inducible factor 1-alphaHomo sapiens (human)
angiogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to hypoxiaHypoxia-inducible factor 1-alphaHomo sapiens (human)
intracellular glucose homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
neural crest cell migrationHypoxia-inducible factor 1-alphaHomo sapiens (human)
epithelial to mesenchymal transitionHypoxia-inducible factor 1-alphaHomo sapiens (human)
embryonic placenta developmentHypoxia-inducible factor 1-alphaHomo sapiens (human)
B-1 B cell homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of endothelial cell proliferationHypoxia-inducible factor 1-alphaHomo sapiens (human)
heart loopingHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of neuroblast proliferationHypoxia-inducible factor 1-alphaHomo sapiens (human)
chondrocyte differentiationHypoxia-inducible factor 1-alphaHomo sapiens (human)
glandular epithelial cell maturationHypoxia-inducible factor 1-alphaHomo sapiens (human)
connective tissue replacement involved in inflammatory response wound healingHypoxia-inducible factor 1-alphaHomo sapiens (human)
outflow tract morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
cardiac ventricle morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
lactate metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of glycolytic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
intracellular iron ion homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
signal transductionHypoxia-inducible factor 1-alphaHomo sapiens (human)
neuroblast proliferationHypoxia-inducible factor 1-alphaHomo sapiens (human)
lactationHypoxia-inducible factor 1-alphaHomo sapiens (human)
visual learningHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to iron ionHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of gene expressionHypoxia-inducible factor 1-alphaHomo sapiens (human)
vascular endothelial growth factor productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of vascular endothelial growth factor productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of gene expressionHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of gene expressionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of epithelial cell migrationHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to muscle activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
axonal transport of mitochondrionHypoxia-inducible factor 1-alphaHomo sapiens (human)
neural fold elevation formationHypoxia-inducible factor 1-alphaHomo sapiens (human)
cerebral cortex developmentHypoxia-inducible factor 1-alphaHomo sapiens (human)
bone mineralizationHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of bone mineralizationHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
TOR signalingHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of TOR signalingHypoxia-inducible factor 1-alphaHomo sapiens (human)
intracellular oxygen homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of chemokine productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of transforming growth factor beta2 productionHypoxia-inducible factor 1-alphaHomo sapiens (human)
collagen metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to oxidative stressHypoxia-inducible factor 1-alphaHomo sapiens (human)
embryonic hemopoiesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
insulin secretion involved in cellular response to glucose stimulusHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusHypoxia-inducible factor 1-alphaHomo sapiens (human)
hemoglobin biosynthetic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of erythrocyte differentiationHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of angiogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of growthHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHypoxia-inducible factor 1-alphaHomo sapiens (human)
muscle cell cellular homeostasisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of hormone biosynthetic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
digestive tract morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of nitric-oxide synthase activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
neuron apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
elastin metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
intestinal epithelial cell maturationHypoxia-inducible factor 1-alphaHomo sapiens (human)
epithelial cell differentiation involved in mammary gland alveolus developmentHypoxia-inducible factor 1-alphaHomo sapiens (human)
iris morphogenesisHypoxia-inducible factor 1-alphaHomo sapiens (human)
retina vasculature development in camera-type eyeHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of thymocyte apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to interleukin-1Hypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to hypoxiaHypoxia-inducible factor 1-alphaHomo sapiens (human)
dopaminergic neuron differentiationHypoxia-inducible factor 1-alphaHomo sapiens (human)
mesenchymal cell apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
hypoxia-inducible factor-1alpha signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
cellular response to virusHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of cytokine production involved in inflammatory responseHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of mitophagyHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of miRNA transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
positive regulation of miRNA transcriptionHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of aerobic respirationHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of reactive oxygen species metabolic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of protein neddylationHypoxia-inducible factor 1-alphaHomo sapiens (human)
negative regulation of mesenchymal cell apoptotic processHypoxia-inducible factor 1-alphaHomo sapiens (human)
regulation of transcription by RNA polymerase IIHypoxia-inducible factor 1-alphaHomo sapiens (human)
response to hypoxiaEndothelial PAS domain-containing protein 1Homo sapiens (human)
angiogenesisEndothelial PAS domain-containing protein 1Homo sapiens (human)
embryonic placenta developmentEndothelial PAS domain-containing protein 1Homo sapiens (human)
blood vessel remodelingEndothelial PAS domain-containing protein 1Homo sapiens (human)
regulation of heart rateEndothelial PAS domain-containing protein 1Homo sapiens (human)
epithelial cell maturationEndothelial PAS domain-containing protein 1Homo sapiens (human)
response to oxidative stressEndothelial PAS domain-containing protein 1Homo sapiens (human)
mitochondrion organizationEndothelial PAS domain-containing protein 1Homo sapiens (human)
signal transductionEndothelial PAS domain-containing protein 1Homo sapiens (human)
visual perceptionEndothelial PAS domain-containing protein 1Homo sapiens (human)
erythrocyte differentiationEndothelial PAS domain-containing protein 1Homo sapiens (human)
lung developmentEndothelial PAS domain-containing protein 1Homo sapiens (human)
norepinephrine metabolic processEndothelial PAS domain-containing protein 1Homo sapiens (human)
mRNA transcription by RNA polymerase IIEndothelial PAS domain-containing protein 1Homo sapiens (human)
surfactant homeostasisEndothelial PAS domain-containing protein 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIEndothelial PAS domain-containing protein 1Homo sapiens (human)
myoblast fate commitmentEndothelial PAS domain-containing protein 1Homo sapiens (human)
multicellular organismal-level iron ion homeostasisEndothelial PAS domain-containing protein 1Homo sapiens (human)
cellular response to hypoxiaEndothelial PAS domain-containing protein 1Homo sapiens (human)
positive regulation of cold-induced thermogenesisEndothelial PAS domain-containing protein 1Homo sapiens (human)
regulation of protein neddylationEndothelial PAS domain-containing protein 1Homo sapiens (human)
regulation of transcription by RNA polymerase IIEndothelial PAS domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (23)

Processvia Protein(s)Taxonomy
DNA-binding transcription factor activity, RNA polymerase II-specificHypoxia-inducible factor 1-alphaHomo sapiens (human)
sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificHypoxia-inducible factor 1-alphaHomo sapiens (human)
cis-regulatory region sequence-specific DNA bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription activator activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription repressor activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
transcription coactivator bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificHypoxia-inducible factor 1-alphaHomo sapiens (human)
p53 bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
DNA-binding transcription factor activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
nuclear receptor bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
enzyme bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein kinase bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein domain specific bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
ubiquitin protein ligase bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
histone deacetylase bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein heterodimerization activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
Hsp90 protein bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
E-box bindingHypoxia-inducible factor 1-alphaHomo sapiens (human)
transcription regulator activator activityHypoxia-inducible factor 1-alphaHomo sapiens (human)
sequence-specific DNA bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEndothelial PAS domain-containing protein 1Homo sapiens (human)
transcription coactivator bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificEndothelial PAS domain-containing protein 1Homo sapiens (human)
protein bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
protein heterodimerization activityEndothelial PAS domain-containing protein 1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingEndothelial PAS domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
nucleusHypoxia-inducible factor 1-alphaHomo sapiens (human)
nucleoplasmHypoxia-inducible factor 1-alphaHomo sapiens (human)
cytoplasmHypoxia-inducible factor 1-alphaHomo sapiens (human)
cytosolHypoxia-inducible factor 1-alphaHomo sapiens (human)
nuclear bodyHypoxia-inducible factor 1-alphaHomo sapiens (human)
nuclear speckHypoxia-inducible factor 1-alphaHomo sapiens (human)
motile ciliumHypoxia-inducible factor 1-alphaHomo sapiens (human)
axon cytoplasmHypoxia-inducible factor 1-alphaHomo sapiens (human)
chromatinHypoxia-inducible factor 1-alphaHomo sapiens (human)
euchromatinHypoxia-inducible factor 1-alphaHomo sapiens (human)
protein-containing complexHypoxia-inducible factor 1-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexHypoxia-inducible factor 1-alphaHomo sapiens (human)
nucleoplasmEndothelial PAS domain-containing protein 1Homo sapiens (human)
cytosolEndothelial PAS domain-containing protein 1Homo sapiens (human)
nuclear speckEndothelial PAS domain-containing protein 1Homo sapiens (human)
chromatinEndothelial PAS domain-containing protein 1Homo sapiens (human)
transcription regulator complexEndothelial PAS domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (84)

Assay IDTitleYearJournalArticle
AID490772Antibacterial activity against Streptococcus mutans ATCC 25175 assessed as decrease in cell viability at 2 time MIC after 60 mins by serial dilution method relative to control2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID325174Inhibition of lipopolysaccharide-induced BALB/c mouse B cell proliferation at 10 uM after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID644114Growth inhibition of human Hep2 cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID1916062Antibacterial activity against Klebsiella pneumoniae ATCC 10031 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID334644Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1287684Cytotoxicity against HEK293 cells after 72 hrs by Cell-Titer Glo assay2016European journal of medicinal chemistry, May-04, Volume: 113Anti-proliferative evaluation of monoterpene derivatives against leukemia.
AID334640Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID334636Toxicity in Salmonella Typhimurium T98 at 150 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID644161Cytotoxicity against human T47D cells2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID325168Cytotoxicity against BALB/c mouse spleen cells at 10 uM after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID325170Inhibition of concanavalin A-induced BALB/c mouse T cell proliferation at 1 uM after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID1666597Induction of DNA damage in human SU8686 cells assessed as increase in gammaH2AX phosphorylation at ser193 at cytotoxic IC50 in presence of 0.3 uM doxorubicin by fluorometry method2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID490660Antibacterial activity against Streptococcus mutans ATCC 25175 after 48 hrs by broth microdilution method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID1916054Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID334643Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID644091Growth inhibition of human PC3 cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID325173Inhibition of lipopolysaccharide-induced BALB/c mouse B cell proliferation at 1 uM after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID164714Compound was tested for minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27852001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID1916056Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC10442 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID490661Antibacterial activity against Actinomyces viscosus ATCC 15987 after 48 hrs by broth microdilution method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID400129Inhibition of replicative DNA polymerase epsilon in SV40 virus infected african green monkey CV1 cells1998Journal of natural products, Mar, Volume: 61, Issue:3
DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia.
AID325175Inhibition of lipopolysaccharide-induced BALB/c mouse B cell proliferation at 100 uM after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID490662Antibacterial activity against Streptococcus sanguinis ATCC 10556 after 48 hrs by broth microdilution method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID644110Growth inhibition of human HeLa cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID334635Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID644108Growth inhibition of human OVCAR5 cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID1825197Cytotoxicity against mouse RAW 264.7 cells assessed as decreased cell viability measured after 24 hrs by MTT assay
AID325171Inhibition of concanavalin A-induced BALB/c mouse T cell proliferation at 10 uM after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1916061Antibacterial activity against Acinetobacter baumannii R2889 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID644094Growth inhibition of human HeLa cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID325172Inhibition of concanavalin A-induced BALB/c mouse T cell proliferation at 100 uM after 48 hrs2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID490663Antibacterial activity against Fusobacterium nucleatum ATCC 10953 after 48 hrs by broth microdilution method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID490763Antibacterial activity against Porphyromonas gingivalis ATCC 33277 after 48 hrs by broth microdilution method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID490770Antibacterial activity against Streptococcus mutans ATCC 25175 assessed as inhibition of biofilm formation after 18 hrs2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID1916058Hemolytic activity in rabbit RBC measured after 1 hrs by multimode reader assay
AID325167Cytotoxicity against BALB/c mouse spleen cells at 1 uM after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID334639Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID325169Cytotoxicity against BALB/c mouse spleen cells at 100 uM after 48 hrs by MTT assay2008Bioorganic & medicinal chemistry, Mar-01, Volume: 16, Issue:5
Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.
AID327963Inhibition of TNF-alpha-induced NF-kappaB activation in human HeLa cells2008Bioorganic & medicinal chemistry letters, Apr-15, Volume: 18, Issue:8
Hypoxia-inducible factor-1 and nuclear factor-kappaB inhibitory meroterpene analogues of bakuchiol, a constituent of the seeds of Psoralea corylifolia.
AID644106Growth inhibition of human A549 cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID123051Compound was tested for minimum inhibitory concentration against Micrococcus luteus ATCC 93412001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID644109Growth inhibition of human IMR32 cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID644093Growth inhibition of human IMR32 cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID1916063Antibacterial activity against Klebsiella pneumoniae ATCC 14581 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID490762Antibacterial activity against Prevotella intermedia ATCC 25611 after 48 hrs by broth microdilution method2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID70577Compound was tested for minimum inhibitory concentration against Escherichia coli ATCC 2592772001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID334641Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID334646Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 600 ug/plate after 72 hrs
AID1287682Cytotoxicity against human Jurkat cells after 72 hrs by Cell-Titer Glo assay2016European journal of medicinal chemistry, May-04, Volume: 113Anti-proliferative evaluation of monoterpene derivatives against leukemia.
AID1287680Cytotoxicity against human HepG2 cells after 72 hrs by Cell-Titer Glo assay2016European journal of medicinal chemistry, May-04, Volume: 113Anti-proliferative evaluation of monoterpene derivatives against leukemia.
AID1287678Cytotoxicity against human NALM6 cells after 72 hrs by Cell-Titer Glo assay2016European journal of medicinal chemistry, May-04, Volume: 113Anti-proliferative evaluation of monoterpene derivatives against leukemia.
AID1287683Cytotoxicity against human BJ cells after 72 hrs by Cell-Titer Glo assay2016European journal of medicinal chemistry, May-04, Volume: 113Anti-proliferative evaluation of monoterpene derivatives against leukemia.
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1916060Antibacterial activity against Acinetobacter baumannii ATCC 17978 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID334648Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 150 ug/plate after 72 hrs
AID327964Cytotoxicity against human HeLa cells by MTT assay2008Bioorganic & medicinal chemistry letters, Apr-15, Volume: 18, Issue:8
Hypoxia-inducible factor-1 and nuclear factor-kappaB inhibitory meroterpene analogues of bakuchiol, a constituent of the seeds of Psoralea corylifolia.
AID327962Cytotoxicity against human AGS cells by MTT assay2008Bioorganic & medicinal chemistry letters, Apr-15, Volume: 18, Issue:8
Hypoxia-inducible factor-1 and nuclear factor-kappaB inhibitory meroterpene analogues of bakuchiol, a constituent of the seeds of Psoralea corylifolia.
AID490774Antibacterial activity against Streptococcus mutans ATCC 25175 assessed as 280 nm absorbing material release at 2 time MIC after 60 mins by spectrophotometric analysis2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID334647Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-nitroflorene-induced mutation at 300 ug/plate after 72 hrs
AID644092Growth inhibition of human OVCAR5 cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID644107Growth inhibition of human PC3 cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID400130Inhibition of replicative DNA polymerase beta in SV40 virus infected african green monkey CV1 cells1998Journal of natural products, Mar, Volume: 61, Issue:3
DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia.
AID644089Growth inhibition of human MCF7 cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID327961Inhibition of hypoxia-induced HIF1 activation in human AGS cells by reporter gene assay2008Bioorganic & medicinal chemistry letters, Apr-15, Volume: 18, Issue:8
Hypoxia-inducible factor-1 and nuclear factor-kappaB inhibitory meroterpene analogues of bakuchiol, a constituent of the seeds of Psoralea corylifolia.
AID334642Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of acetylaminofluorene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1287679Cytotoxicity against human SEM cells after 72 hrs by Cell-Titer Glo assay2016European journal of medicinal chemistry, May-04, Volume: 113Anti-proliferative evaluation of monoterpene derivatives against leukemia.
AID644115Growth inhibition of human Hep2 cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID400131Inhibition of replicative DNA polymerase gamma in SV40 virus infected african green monkey CV1 cells1998Journal of natural products, Mar, Volume: 61, Issue:3
DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia.
AID644095Growth inhibition of human THP1 cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID334634Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID334638Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 300 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID644160Cytotoxicity against human MDA-MB-231 cells2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID644105Growth inhibition of human MCF7 cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID205807Compound was tested for minimum inhibitory concentration against Staphylococcus aureus ATCC 259232001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.
AID1287681Cytotoxicity against human Raji cells after 72 hrs by Cell-Titer Glo assay2016European journal of medicinal chemistry, May-04, Volume: 113Anti-proliferative evaluation of monoterpene derivatives against leukemia.
AID1916057Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID1916055Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID1916059Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI based broth dilution method
AID490773Antibacterial activity against Streptococcus mutans ATCC 25175 assessed as increase of cell membrane permeability at 2 time MIC after 60 mins propidium iodide staining by flow cytometry2010European journal of medicinal chemistry, Jul, Volume: 45, Issue:7
Novel bisstyryl derivatives of bakuchiol: targeting oral cavity pathogens.
AID334645Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of benzo[a]pyrene-induced mutation at 150 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID644111Growth inhibition of human THP1 cells at 30 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
AID644090Growth inhibition of human A549 cells at 50 uM after 48 hrs by sulpharhodamine B assay2012European journal of medicinal chemistry, Mar, Volume: 49Bakuchiol derivatives as novel and potent cytotoxic agents: a report.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (125)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (2.40)18.7374
1990's5 (4.00)18.2507
2000's18 (14.40)29.6817
2010's65 (52.00)24.3611
2020's34 (27.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.46 (24.57)
Research Supply Index4.92 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index206.20 (26.88)
Search Engine Supply Index3.99 (0.95)

This Compound (62.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (3.82%)5.53%
Reviews8 (6.11%)6.00%
Case Studies2 (1.53%)4.05%
Observational1 (0.76%)0.25%
Other115 (87.79%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]